Bivalent Norovirus Vaccine Study

NCT01168401 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroenteritis

Interventions

BIOLOGICAL: NoV GI.1/GII.4 Bivalent VLP Vaccine
BIOLOGICAL: Saline

Sponsor

Takeda